
Publikationen von MD Hartmann
Alle Typen
Zeitschriftenartikel (69)
1.
Zeitschriftenartikel
389 (6755), S. 32 - 33 (2025)
Expanding the reach of molecular glue degraders. Science 2.
Zeitschriftenartikel
11 (15), eadr5235 (2025)
Discovery of synthetic small molecules targeting the central regulator of Salmonella pathogenicity. Science Advances 3.
Zeitschriftenartikel
35 (3) (2025)
Catalytic Castagnoli–Cushman reaction-based synthesis of tetrahydroisoquinolone–glutarimide dyads and their evaluation as potential cereblon ligands. Mendeleev Communications 4.
Zeitschriftenartikel
35 (1), S. 69 - 72 (2025)
Synthesis of α-(azidomethyl)glutarimide and its applicationin construction of potential Cereblon ligands via the CuAAC reaction. Mendeleev Communications 5.
Zeitschriftenartikel
A Strategy to Design Protein-based Antagonists Against Type I Cytokine Receptors. PLOS Biology (angenommen)
6.
Zeitschriftenartikel
15 (1), 7950 (2024)
Histones and histone variant families in prokaryotes. Nature Communications 7.
Zeitschriftenartikel
52 (14), gkae485, S. 8193 - 8204 (2024)
Bacterial histone HBb from Bdellovibrio bacteriovorus compacts DNA by bending. Nucleic Acids Research 8.
Zeitschriftenartikel
270, 116328 (2024)
Discovery and characterization of potent spiro-isoxazole-based cereblon ligands with a novel binding mode. European Journal of Medicinal Chemistry 9.
Zeitschriftenartikel
15 (1), S. 4 - 5 (2024)
TRIM for Tissue Specificity. ACS Medicinal Chemistry Letters 10.
Zeitschriftenartikel
299 (12), 105387 (2023)
HilE represses the activity of the Salmonella virulence regulator HilD via a mechanism distinct from that of intestinal long-chain fatty acids. The Journal of Biological Chemistry 11.
Zeitschriftenartikel
63 (21), S. 6925 - 6937 (2023)
Computational Prediction of Cyclic Peptide Structural Ensembles and Application to the Design of Keap1 Binders. Journal of Chemical Information and Modeling 12.
Zeitschriftenartikel
66 (21), S. 14513 - 14543 (2023)
Leveraging Ligand Affinity and Properties: Discovery of Novel Benzamide-Type Cereblon Binders for the Design of PROTACs. Current Medicinal Chemistry 13.
Zeitschriftenartikel
4 (3), S. 229 - 234 (2023)
Accessing three-branched high-affinity cereblon ligands for molecular glue and protein degrader design. RSC Chemical Biology 14.
Zeitschriftenartikel
120 (8), e2205882120 (2023)
Carbon signaling protein SbtB possesses atypical redox-regulated apyrase activity to facilitate regulation of bicarbonate transporter SbtA. Proceedings of the National Academy of Sciences of the United States of America 15.
Zeitschriftenartikel
646, S. 30 - 35 (2023)
Cereblon neo-substrate binding mimics the recognition of the cyclic imide degron. Biochemical and Biophysical Research Communications 16.
Zeitschriftenartikel
637, S. 66 - 72 (2022)
Identification and structural basis of C-terminal cyclic imides as natural degrons for cereblon. Biochemical and Biophysical Research Communications 17.
Zeitschriftenartikel
246, 114990 (2022)
Synthesis of novel glutarimide ligands for the E3 ligase substrate receptor Cereblon (CRBN): Investigation of their binding mode and antiproliferative effects against myeloma cell lines. European Journal of Medicinal Chemistry 18.
Zeitschriftenartikel
37 (1), S. 527 - 530 (2022)
Replacing the phthalimide core in thalidomide with benzotriazole. Journal of Enzyme Inhibition and Medicinal Chemistry 19.
Zeitschriftenartikel
32 (6), S. 747 - 749 (2022)
Synthesis of novel glutarimide derivatives via the Ugi multicomponent reaction: affinity towards the E3 ubiquitin ligase substrate receptor Cereblon. Mendeleev Communications 20.
Zeitschriftenartikel
289 (17), S. 5305 - 5321 (2022)
PotN represents a novel energy-state sensing PII subfamily, occurring in firmicutes. The FEBS Journal